(Hypertension. 1998;32:849-855.)
© 1998 American Heart Association, Inc.
Scientific Contributions |
Role of Nitric Oxide in Cyclosporine A–Induced Hypertension
From the Hypertension-Endocrine Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Md.
Correspondence to Dr Gibson K. Oriji, Hypertension-Endocrine Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, 10 Center Dr, MSC 1754, Bldg 10, Room 8C103, Bethesda, MD 20892-1754.
Abstract—Cyclosporine A (CsA) is an immunosuppressive agent that also causes hypertension. The effect of CsA on vascular responses was determined in Sprague-Dawley rats and isolated rat aortic rings. Male rats weighing 250 to 300 g were given either CsA (25 mg · kg-1 · d-1) in olive oil or vehicle by intraperitoneal injection for 7 days. CsA administration produced a 42% increase (P<0.001) in mean arterial pressure (MAP) that reached a plateau after 3 days. Conversely, the levels of both nitrate/nitrite, metabolites of nitric oxide (NO), and cGMP, which mediates NO action, decreased by 50% (P<0.001) and 35% (P<0.001), respectively, in the urine. Thoracic aortic rings from rats treated with CsA and precontracted with endothelin (10-9 mol/L) showed a 35% increase (P<0.001) in tension, whereas endothelium-dependent relaxation induced by acetylcholine (ACh, 10-9 mol/L) was inhibited 65% (P<0.001) compared with that in untreated rats. This response was similar to that of endothelium-denuded aortic rings from untreated rats in which ACh-induced relaxation was completely abolished (P<0.001), but relaxation induced by S-nitroso-N-acetylpenicillamine (SNAP, 10-8 mol/L) was unaffected (P<0.001). ACh-induced formation of both nitrate/nitrite and cGMP by both denuded and CsA-treated aortic rings was inhibited 95% (P<0.001) and 65% (P<0.001), respectively, compared with intact aortic rings. The effects of CsA were reversed both in vivo and in vitro by pretreatment with L-arginine (10 mg · kg-1 · d-1 IP), the precursor of NO. There were no changes in MAP and tension in rats treated with L-arginine alone. In summary, CsA inhibits endothelial NO activity, with resulting increases in MAP and tension, and this inhibition can be overcome by parenteral administration of L-arginine.
Key Words: cyclosporine • arginine • endothelin • acetylcholine • nitrates • rats • aortic rings
This article has been cited by other articles:
 |
|
 |
|
  C. Esteva-Font, E. Ars, E. Guillen-Gomez, J. M. Campistol, L. Sanz, W. Jimenez, M. A. Knepper, F. Torres, R. Torra, J. A. Ballarin, et al. Ciclosporin-induced hypertension is associated with increased sodium transporter of the loop of Henle (NKCC2) Nephrol. Dial. Transplant., October 1, 2007; 22(10): 2810 - 2816. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Slattery, E. Campbell, T. McMorrow, and M. P. Ryan Cyclosporine A-Induced Renal Fibrosis: A Role for Epithelial-Mesenchymal Transition Am. J. Pathol., August 1, 2005; 167(2): 395 - 407. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Tsuruoka, G. J. Schwartz, M. Wakaumi, K. Nishiki, H. Yamamoto, J. M. Purkerson, and A. Fujimura Nitric Oxide Production Modulates Cyclosporin A-Induced Distal Renal Tubular Acidosis in the Rat J. Pharmacol. Exp. Ther., June 1, 2003; 305(3): 840 - 845. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Vetter, Z.-J. Chen, G.-D. Chang, D. Che, S. Liu, and C.-H. Chang Cyclosporin A Disrupts Bradykinin Signaling Through Superoxide Hypertension, May 1, 2003; 41(5): 1136 - 1142. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Zhang Old and new tools to dissect calcineurin's role in pressure-overload cardiac hypertrophy Cardiovasc Res, February 1, 2002; 53(2): 294 - 303. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. D. Vaziri, K. Liang, and H. Azad Effect of Cyclosporine on HMG-CoA Reductase, Cholesterol 7alpha -Hydroxylase, LDL Receptor, HDL Receptor, VLDL Receptor, and Lipoprotein Lipase Expressions J. Pharmacol. Exp. Ther., August 1, 2000; 294(2): 778 - 783. [Abstract] [Full Text]
|
|
|
|
|
|
J. Galle, C. Lehmann-Bodem, U. Hubner, A. Heinloth, and C. Wanner CyA and OxLDL cause endothelial dysfunction in isolated arteries through endothelin-mediated stimulation of O2- formation Nephrol. Dial. Transplant., March 1, 2000; 15(3): 339 - 346. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Navarro-Antolin, J. Rey-Campos, and S. Lamas Transcriptional Induction of Endothelial Nitric Oxide Gene by Cyclosporine A. A ROLE FOR ACTIVATOR PROTEIN-1 J. Biol. Chem., February 4, 2000; 275(5): 3075 - 3080. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. B. Harris, H. Ju, V. J. Venema, H. Liang, R. Zou, B. J. Michell, Z.-P. Chen, B. E. Kemp, and R. C. Venema Reciprocal Phosphorylation and Regulation of Endothelial Nitric-oxide Synthase in Response to Bradykinin Stimulation J. Biol. Chem., May 4, 2001; 276(19): 16587 - 16591. [Abstract] [Full Text] [PDF]
|
|